ApiJect Announces the Opening of the ApiJect Technology Development Center
New Facility Brings to the U.S. Critical Capabilities for the Design, Engineering and Testing of ApiJect’s High Volume Manufacturing Process for Making Single-Dose, Prefilled Syringes. Stamford, CT., April 13, 2022 — ApiJect Systems, Corp., a medical technology public-benefit corporation that will transform…
ApiJect Announces Proof-of-Concept in Blow-Fill-Seal at Orlando Technology Development Center – Opportunity to “Test Drive” ApiJect Technology –
Orlando, FL, February 28, 2024 – ApiJect Systems, Corp., a medical technology public-benefit corporation, announced it has added product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS)…
Test Drive Our Technology
Apiject has added product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS) using ApiJect prefilled injector technology. Higher volumes may be needed based on the specific requirements…